Clinical Trial Update: Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy given after GM-CSF for treating multiple myeloma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• sargramostim (sargramostim)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED